$LFT

Aquis Exchange Weekly Movers: LFT Jumps 64% on FourJaw Stake

Aquis Exchange weekly movers: Lift Global Ventures (LON: LFT) rose 64.3% to 0.575p after acquiring a 2.18% stake in FourJaw for £150,000 paid in new LFT shares. WeCap (LON: WCAP) gained 15.4% on WeShop’s Russell 3000 addition. Coinsilium (LON: COIN) rose 15% on a chairman share purchase. Vault Ventures (LON: VULT) fell 11.8% after a £2.12m impairment; Vaultz Capital (LON: V3TC) slipped 3.92% ahead of a 21 July Bitcoin disposal vote.

Original reporting
Published Jul 14, 2026, 2:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 14, 2026, 2:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Aquis Exchange Weekly Movers: LFT Jumps 64% on FourJaw Stake — source image
Decision brief

The 30-second read

$LFTBullishMed
01

Why it matters

LFT’s share-for-share stake purchase is a direct deal catalyst supporting momentum trading. VULT’s impairment and operating cash outflow are negative fundamentals that can pressure sentiment. V3TC’s 21 July shareholder vote is a clear binary event that can drive volatility and positioning around approval odds.

02

Market read

Traders can act on three distinct, disclosed catalysts: a stake acquisition (LFT), impairment and cash outflow (VULT), and a dated shareholder vote on Bitcoin disposal (V3TC).

03

What to watch

For V3TC, the market may be underpricing the probability-weighted outcome of the vote and the expected timing/price of any Bitcoin disposal, which can dominate near-term returns.

Relevance 7/10Novelty 6/10Timing: into the 21 July Vaultz Capital shareholder vote; same-week reaction to LFT and VULT disclosures

Background

This is a weekly movers wrap on Aquis Exchange, with the main disclosed catalysts being LFT’s stake acquisition, VULT’s impairment and cash outflow, and V3TC’s upcoming Bitcoin policy withdrawal vote.

Company-level read

Ticker impact

$LFTBullishMedium confidence
Context

Lift Global Ventures shares jumped 64.3% after acquiring a 2.18% stake in FourJaw via a £150,000 share-for-share exchange.

Expected impact

Near-term upside bias while traders price in deal execution and any follow-on disclosures.

Evidence & confidence

The article provides the consideration (£150,000), structure (new LFT shares), and the immediate price reaction, but not longer-term financial impact or guidance.

Market effects

Highlights how UK-listed microcaps can re-rate sharply on small but structured stake deals (LFT) and how impairments/cash burn can quickly pressure valuations (VULT).

Primarily UK small-cap sentiment, with a Bitcoin-linked governance event (V3TC) adding cross-asset sensitivity.

Limited global spillover; only the Bitcoin disposal vote introduces a potential linkage to broader crypto risk appetite.

Counterpoint

LFT’s surge may fade if the stake acquisition is small relative to market cap or if FourJaw’s commercial traction is not yet proven; VULT’s impairment could be non-cash and not reflect near-term solvency.

Key entities

  • Lift Global Ventures

    Acquired a 2.18% stake in FourJaw via a £150,000 share-for-share exchange, triggering a 64.3% weekly jump.

  • Vault Ventures

    Reported a £2.12m non-cash impairment and £2.85m operating cash outflow, leading to an 11.8% decline.

  • Vaultz Capital

    Called a 21 July general meeting to withdraw its Bitcoin treasury policy and dispose of Bitcoin holdings.

Related articles

$LFTHigh

Lument Finance (LFT) Q2 2026 Earnings Call Transcript

Lument Finance (LFT) reported a Q2 2026 net loss of $9.2M ($0.18/share) and a distributable loss of $5.3M ($0.10/share). The company discussed challenges in resolving legacy assets and improving market conditions for multifamily investments. LFT announced a 10-for-1 reverse stock split, effective September 9, to maintain NYSE compliance and support market efficiency. Management remains focused on asset resolution and capital redeployment for 2027.

$LFTMed

Lument Finance Trust, Inc. (LFT): Results of Operations and Financial Condition

Lument Finance Trust, Inc. (LFT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Lument Finance Trust Reports Second Quarter 2026 Results and Announces Reverse Stock Split NEW YORK, August 13, 2026 /PRNewswire/ — Lument Finance Trust, Inc. (NYSE: LFT) (“we”, “LFT” or “the Company”) today reported its second quarter results and also announced that

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

$XOMMed

Piper Sandles Sees ExxonMobil (XOM) Heading Toward New Highs

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.